A multi-arm, randomized, parallel, partially double-blind study conducted in healthy participants with elevated LDL-C and Lp(a) to evaluate the safety, tolerability, and efficacy of multiple doses of FB7023 injection. (ChiCTR) - Oct 16, 2026 - P=N/A | N=27 | Recruiting | Sponsor: Zhejiang Xiaoshan Hospital; Zhejiang Xiaoshan Hospital
New trial • Dyslipidemia • Metabolic Disorders
|